Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
Arthritis Research & Therapy · 20.03.2024 · 26 (1)
DOI: 10.1186/s13075-024-03300-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, online erschienen am 20.03.2024. Verfasst von Ann-Christin Pecher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Scleroderma, Systemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.
Abstract (Originalsprache)
Background
Treatment with high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (aHSCT) is an intensive treatment option for patients with severe forms of systemic sclerosis (SSc). Even though associated with a high treatment related mortality, the results in this high-risk population are generally favourable. The knowledge on the potential mechanism of action of this therapy and how it can improve patients with SSc is crucial to better select the right patients for aHSCT.
Methods
This is a monocentric retrospective study from Tübingen, Germany, including 32 patients who underwent aHSCT. Peripheral blood samples were analysed for different lymphocyte subsets at various timepoints before and after aHSCT. Patients were divided into responders and non-responders according to the modified Rodnan skin score and lung function test in the three years following aHSCT.
Results
Responders showed significantly lower levels of cluster of differentiation (CD)4 positive T cells in the first months after aHSCT (month 1 and 3), B cells (month 3 and 6 after aHSCT) and natural killer cells (month 1). Mantel-cox test showed a significant deviation of the probability curves, i.e. patients with lower CD4 + T cells and natural killer cells one month and B cells after 3 months after stem cell transplantation had a higher probability to belong to the responder group.
Conclusions
Taken together, this study supports the theory that a profound CD4 + T cell and B cell lymphopenia is important for patients with SSc to achieve a sustained response after aHSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen, Germany. ann-christin.pecher@med.uni-tuebingen.de.
- Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen, Germany.
- Division of Rheumatology and Systemic Inflammatory Rheumatic Diseases, University Hospital Hamburg-Eppendorf and Clinic for Rheumatology and Immunology, Bad Bramstedt, Germany.
Förderung
- Universitätsklinikum Tübingen
Zitieren
APA
Pecher, A. C., Klein, R., Koetter, I., Wagner, M., Vogel, W., Wirths, S., Lengerke, C., & Henes, J. C. (2024). Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-024-03300-1
Vancouver
Pecher AC, Klein R, Koetter I, Wagner M, Vogel W, Wirths S, et al. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome. Arthritis Research & Therapy. 2024;26(1). doi:10.1186/s13075-024-03300-1
BibTeX
@article{Pecher2024,
author = {Pecher, Ann-Christin and Klein, Reinhild and Koetter, Ina and Wagner, Marieke and Vogel, Wichard and Wirths, Stefan and Lengerke, Claudia and Henes, Joerg Christoph},
title = {Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome},
journal = {Arthritis Research & Therapy},
year = {2024},
volume = {26},
number = {1},
doi = {10.1186/s13075-024-03300-1}
}
EUVIMED